脳震盪市場レポート：2030年までの動向、予測、競合分析

脳震盪の動向と予測

世界の脳震盪市場は、2024年から2030年までのCAGRが3.9%で、2030年までに推定97億8,000万米ドルに達すると予想されます。この市場の主な促進要因は、スポーツや交通事故による傷害件数の増加、高齢化人口の増加、世界中で研究開発活動が活発化していることです。世界の脳震盪市場の将来は、病院・診療所市場や診断センター市場にビジネスチャンスがあり、有望視されています。

脳震盪市場の洞察

Lucintelの予測では、世界中で脳損傷の症例数が増加しているため、診断が予測期間中に高い成長を遂げる見込みです。

この市場において、病院・診療所は、高度な医療機器や有利な償還制度が利用可能であること、また治療方法として病院を好む人が増えていることから、最大セグメントであり続けるでしょう。

北米は、脳損傷に起因する脳震盪の発生率の上昇と、政府機関や民間企業による啓発活動の増加により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.今後成長が加速するセグメントとその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の脳震盪市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の脳震盪市場動向（2018-2023）と予測（2024-2030）
• タイプ別の世界の脳震盪市場
  • 診断
  • 治療
• 最終用途別の世界の脳震盪市場
  • 病院とクリニック
  • 診断センター
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の脳震盪市場
• 北米脳震盪市場
• 欧州脳震盪市場
• アジア太平洋脳震盪市場
• その他地域脳震盪市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の脳震盪市場の成長機会
  • 最終用途別の世界の脳震盪市場の成長機会
  • 地域別の世界の脳震盪市場の成長機会
• 世界の脳震盪市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の脳震盪市場の能力拡大
  • 世界の脳震盪市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Zydus Cadila
• Novartis
• Lupin
• Mylan
• Medtronic
• Pfizer
• Sanofi
• InfraScan
• Oculogica
• Raumedic

Concussion Trends and Forecast

The future of the global concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global concussion market is expected to reach an estimated $9.78 billion by 2030 with a CAGR of 3.9% from 2024 to 2030. The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Concussion by Segment

The study includes a forecast for the global concussion by type, end use, and region.

Concussion Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Diagnosis
• Treatment

Concussion Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Centers
• Others

Concussion Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Concussion Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies concussion companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the concussion companies profiled in this report include-

• Zydus Cadila
• Novartis
• Lupin
• Mylan
• Medtronic
• Pfizer
• Sanofi
• Infrascan
• Oculogica
• Raumedic
• BioDirection

Concussion Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Within this market, hospitals & clinics will remain the largest segment due to avialability of advanced medical equipment and favorable reimbursement facilities and increasing preference of people towards hospitals as a preffered mode of treatment.

North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Features of the Global Concussion Market

Market Size Estimates: Concussion market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Concussion Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Concussion market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the concussion market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the concussion market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the concussion market size?

Answer: The global concussion market is expected to reach an estimated $9.78 billion by 2030.

Q.2 What is the growth forecast for concussion market?

Answer: The global concussion market is expected to grow with a CAGR of 3.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the concussion market?

Answer: The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

Q4. What are the major segments for concussion market?

Answer: The future of the concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets.

Q5. Who are the key Concussion Market companies?

Answer: Some of the key concussion companies are as follows:

• Zydus Cadila
• Novartis
• Lupin
• Mylan
• Medtronic
• Pfizer
• Sanofi
• InfraScan
• Oculogica
• Raumedic

Q6. Which concussion market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Q7. In concussion market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the concussion market by type (diagnosis and treatment), end use (hospitals and clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Concussion Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Concussion Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Concussion Market by Type
  • 3.3.1: Diagnosis
  • 3.3.2: Treatment
• 3.4: Global Concussion Market by End Use
  • 3.4.1: Hospitals & Clinics
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Concussion Market by Region
• 4.2: North American Concussion Market
  • 4.2.2: North American Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.3: European Concussion Market
  • 4.3.1: European Concussion Market by Type: Diagnosis and Treatment
  • 4.3.2: European Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.4: APAC Concussion Market
  • 4.4.1: APAC Concussion Market by Type: Diagnosis and Treatment
  • 4.4.2: APAC Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
• 4.5: ROW Concussion Market
  • 4.5.1: ROW Concussion Market by Type: Diagnosis and Treatment
  • 4.5.2: ROW Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Concussion Market by Type
  • 6.1.2: Growth Opportunities for the Global Concussion Market by End Use
  • 6.1.3: Growth Opportunities for the Global Concussion Market by Region
• 6.2: Emerging Trends in the Global Concussion Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Concussion Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Concussion Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Zydus Cadila
• 7.2: Novartis
• 7.3: Lupin
• 7.4: Mylan
• 7.5: Medtronic
• 7.6: Pfizer
• 7.7: Sanofi
• 7.8: InfraScan
• 7.9: Oculogica
• 7.10: Raumedic